Viking Therapeutics is targeting two monster markets. David Jagielski (CRISPR Therapeutics): Biotech company CRISPR ...

The Bank of England is facing pressure to hold onto more than a quarter of its bond holdings, potentially for decades, after ...

The sector is facing a perfect storm. Chinese spending, the industry’s growth engine for so long, has stalled. There are ...